OLLI at WVU and the Committee of Retired Faculty will host John Barnett, president and chief scientific officer of ExesaLibero Pharma, as he discusses the development of ELP-004 in the treatment of bone degradation associated with arthritis, cancer and more at 2:30 p.m. today (March 5) on Zoom.